On Friday shares of Magnum Hunter Resources Corp. (NYSE:MHR) closed at $2.26. Company’s sales growth for last 5 years was 124.90% and EPS growth for next 5 years is recorded as -6.13%. On 17 April, Magnum Hunter Resources Corp (NYSE:MHR) declared that it has declared a monthly cash dividend on the Company’s 10.25% Series C Cumulative Perpetual Preferred Stock (“Series C Preferred Stock”), a monthly cash dividend on the Company’s 8.0% Series D Cumulative Preferred Stock (“Series D Preferred Stock”) and a monthly cash dividend on the Company’s 8.0% Series E Cumulative Convertible Preferred Stock (“Series E Preferred Stock”).
NXP Semiconductors NV (NASDAQ:NXPI) in last trading activity fell -3.30% to close at $95.33. Company weekly performance is -4.41% while its quarterly performance stands at 18.82%. NXP Semiconductors NV (NASDAQ:NXPI) is -12.14% away from its 52 week high. NXP Semiconductors N.V. (NASDAQ:NXPI) on 21 April, announced that two of its engineers have been nominated for the highly-respected and acclaimed EPO European Inventor Award. Franz Amtmann and Philippe Maugars, along with their teams, have been recognized due to their work in the milestone creation of near field communication (NFC).
On Friday shares of CME Group Inc. (NASDAQ:CME) closed at $89.89. Company’s sales growth for last 5 years was 3.60% and EPS growth for next 5 years is recorded as 12.77%. CME Group Inc. (NASDAQ:CME) denied on Wednesday allegations that the futures markets caused the flash crash. CME said it was prohibited by law from releasing any information on Sarao, who owned a seat on the exchange.
TG Therapeutics, Inc. (NASDAQ:TGTX) has 9.40% insider ownership while its institutional ownership stands at 50.70%. In last trading activity company’s stock closed at $16.23. Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner TG Therapeutics, Inc. (NASDAQ:TGTX) on 20 April, announced the first presentation of preclinical data demonstrating single agent and combination activity of two of TG Therapeutics’ IRAK4 inhibitor compounds under development. This pre-clinical data was presented yesterday at the 106th Annual Meeting of the American Association for Cancer Research (AACR), held in Philadelphia, PA.
On last trading day Kosmos Energy Ltd. (NYSE:KOS) moved up 0.23% to close at $8.69. Its volatility for the week is 2.47% while volatility for the month is 3.00%. KOS’s sales growth for past 5 years was 142.70% and its EPS growth for past 5 years was 32.30%. Kosmos Energy Ltd. (NYSE:KOS) monthly performance is 7.82%. Kosmos Energy (NYSE:KOS) had its price objective decreased by Jefferies Group from $11.00 to $10.00 in a research report released on Friday. Jefferies Group currently has a buy rating on the stock.